InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Claiborne Cary J. Insider active across 1 company, notably Adial Pharmaceuticals, INC.. Cumulatively, 5 reports have been published. History available since 18 August 2022. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Claiborne Cary J is a declarant linked to Adial Pharmaceuticals, INC., where the company lists the role of Chief Executive Officer. The record shows 4 filings in total, and the 4 sampled filings cover the period from 2022-08-22 to 2023-05-25, with the transaction nature shown as Attribution and buy and sell amounts of 0.